ClinicalTrials.gg
WithdrawnNCT03318952Updated Nov 3, 2022

Articaine vs Lidocaine for Pediatric Dental Procedures

A Phase 4 interventional study of lidocaine and articaine in Anesthesia, Dental and Pain, Postoperative, sponsored by Boston University. Withdrawn at 1 site in United States. Open to participants aged 4 Years to 14 Years. Per ClinicalTrials.gov, last updated 2022-11-03.

Sponsored by Boston University · Phase 4, Interventional, and Treatment

Why this study was withdrawn
The research did not start and the PI transitioned to another institution.
Phase
Phase 4
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
4 Years to 14 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 116 studies testing lidocaine in Pain, Postoperative — 12 open to participants now, 15 under way, 5 of them phase 3. Lidocaine · Pain, Postoperative.

Enrollment
113th of 116
0 · median 80
Started
2022
with 6 others
Phase 4
40 of 116
none open now
Registered
41st of 116
by date

Among the 116 studies testing lidocaine in Pain, Postoperative, this one is the 113th largest by enrollment, is one of 7 that started in 2022, is one of 40 in phase 4, and was the 41st registered.

By phase

116 studies; the count open now beside each. This study's row is marked.

No phase40 · 7 open
Phase 4this study40 · 0 open
Phase 319 · 2 open
Phase 27 · 2 open
Phase 2/35 · 1 open
Phase 14 · 0 open
Phase 1/21 · 0 open

By the year they started

First in 2003; this study’s year is marked. 7 started in 2022.

Size and results

Median enrollment 80 across the 116 interventional studies. Of the 79 that completed or were terminated, 11 (14%) have results posted.

Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 116 studies testing lidocaine in Pain, Postoperative, or all of them as a file.
02

Study summary

The purpose of this study is to compare the efficacy of two types of local anesthesia (articaine and lidocaine) for infiltration anesthesia during restorative dental procedures on lower teeth in pediatric patients. The patients will require similar dental operative procedures on both right and left sides of the mandible in order to qualify for this study. The study will require at least two dental appointments, where a randomized, cross-over study methodology will be utilized. All subjects will be treated by the same dentist. The comfort of the patient will be assessed at various points during the procedure using the Wong-Baker Faces Scale.

Read the detailed description

This study will compare articaine to lidocaine with overall quality of anesthesia. When administering lidocaine, the investigator will follow standard of care by administering a buccal infiltration injection followed by 2-3 interpapillary injections, one at each gingival papilla where the rubber dam clamp will be placed and possibly more if needed in areas where dental treatment will be provided. A single buccal infiltration injection of articaine will be administered, with the hypothesis that articaine is a stronger anesthestic and will deliver palatal anesthesia with a single injection, eliminating the interpapillary injections required for lidocaine to achieve adequate soft tissue anesthesia. The comfort of the patient during multiple steps of the dental treatment will be recorded. A randomized, cross-over methodology will be used. This study seeks to find whether adequate anesthesia in the mandible can be achieved with a single injection of articaine in the buccal aspect of the jaw instead of having to administer multiple injections of lidocaine, which can increase patient anxiety and discomfort. By decreasing the number of injections needed for children during dental treatment while providing adequate local anesthesia, dentists can provide more comfortable care to their pediatric patients.

Specific Aims/ Hypothesis

-Specific Aim 1: To compare articaine to lidocaine with achieving effective local anesthesia in the mandible and upper arch of pediatric dental patients.

Hypothesis: The solubility of articaine will provide more effective anesthetic delivery through the soft and hard tissue of the mandible following buccal infiltration, eliminating the need for multiple injections.

-Specific Aim 2: To identify which type of anesthetic provides the best patient experience by way of measuring patient comfort at various stages of the dental procedure.

Hypothesis: The patient will have an equally comfortable experience during the dental procedure when articaine or lidocaine is used.

03

Conditions studied

  • Anesthesia, Dental
  • Pain, Postoperative

Browse trials for

Keywords

  • lidocaine injection
  • articaine injections
  • pediatric dental anesthesia
  • post dental procedure pain
04

Who can participate

Ages eligible
4 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients receiving dental care at Boston Medical Center Pediatric Dental Clinic, Boston University Pediatric Oral Health Center, and East Boston Neighborhood Health Center Pediatric Dental Clinic
  • Patients needing similar restorative dental procedures to primary molar teeth on both sides of the maxillary arch or upper arch
  • Boys and girls between ages 4 to 14 years
  • English speaking and be able to understand verbal assent.

Exclusion criteria

Exclusion Criteria:

  • Patients for whom the use of articaine is such as patients with Acetylcholine esterase deficiency
  • Patients for whom the use of lidocaine is contraindicated in patients taking metronidazole
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    lidocaine then articaine

    For the first dental procedure 2% lidocaine with 1:100,000 epinephrine will be administered with a buccal infiltration injection followed by 2-3 interpapillary injections and possibly more if needed. For the second dental procedure a single buccal infiltration injection of 4% articaine with 1:100,000 epinephrine will be administered.

    Drug: lidocaine · Drug: articaine

  • Experimental
    articaine then lidocaine

    For the first dental procedure a single buccal infiltration injection of 4% articaine with 1:100,000 epinephrine will be administered. For the second dental procedure 2% lidocaine with 1:100,000 epinephrine will be administered with a buccal infiltration injection followed by 2-3 interpapillary injections and possibly more if needed.

    Drug: lidocaine · Drug: articaine

Interventions

  • A buccal infiltration injection followed by 2-3 interpapillary injections and possibly more if needed of 2% lidocaine with 1:100,000 epinephrine will be administered.

    Also known as: local anesthetic

  • A single buccal infiltration injection of 4% articaine with 1:100,000 epinephrine will be administered

    Also known as: local anesthetic

06

What researchers measure

Primary outcomes

  1. Pain during anesthesia injection using the Wong-Baker faces scale

    Wong-Baker faces scale is a set of six cartoon faces with varying facial expressions ranging from a smile/laughter to tears. Each face has a numeric value with a range of 1 to 10. The higher the numeric value the more intense the pain.

    Time frame: Anesthesia injection is usually about 10 min before the dental procedure starts.

  2. Pain during rubber dam placement using the Wong-Baker faces scale

    Wong-Baker faces scale is a set of six cartoon faces with varying facial expressions ranging from a smile/laughter to tears. Each face has a numeric value with a range of 1 to 10. The higher the numeric value the more intense the pain.

    Time frame: Rubberdam placement is usually about 5 min before the dental procedure starts.

  3. Pain during tooth preparation using the Wong-Baker faces scale

    Wong-Baker faces scale is a set of six cartoon faces with varying facial expressions ranging from a smile/laughter to tears. Each face has a numeric value with a range of 1 to 10. The higher the numeric value the more intense the pain.

    Time frame: Tooth preparation occurs during the dental procedure.

  4. Pain during pulp opening using the Wong-Baker faces scale

    Wong-Baker faces scale is a set of six cartoon faces with varying facial expressions ranging from a smile/laughter to tears. Each face has a numeric value with a range of 1 to 10. The higher the numeric value the more intense the pain.

    Time frame: Pulp opening occurs during the dental procedure.

  5. Pain during restoration placement using the Wong-Baker faces scale

    Wong-Baker faces scale is a set of six cartoon faces with varying facial expressions ranging from a smile/laughter to tears. Each face has a numeric value with a range of 1 to 10. The higher the numeric value the more intense the pain.

    Time frame: Restoration placement is at the end of the dental procedure, approximately 1 hour.

Secondary outcomes

  1. Additional injections of local anesthetic at the first visit

    The number of extra injections to achieve anesthesia will be documented for each participant.

    Time frame: At the completion of the first visit, approximately 1 hour.

  2. Additional injections of local anesthetic at the second visit

    The number of extra injections to achieve anesthesia will be documented for each participant.

    Time frame: At the completion of the second visit, approximately 1 hour.

07

Study locations

1 site
  • BU Henry M. Goldman School of Dental Medicine
    Boston, Massachusetts 02118, United States
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 3, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03318952
Lead sponsor
Boston University
Responsible party
Sponsor
First posted
Oct 24, 2017
Start date
Sep 2022 (estimated)
Primary completion
Jun 2023 (estimated)
Completion
Jun 2023 (estimated)
Last update
Nov 3, 2022

Study contacts

Jayapriyaa Shanmugham, BDS MPH DrPH
principal investigator · BU Henry M. Goldman School of Dental Medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Lidocaine · Carticaine

Start the discussion